Log in to save to my catalogue

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_017baefb71394890b530b34dca8c17fc

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

About this item

Full title

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Annals of Clinical and Translational Neurology, 2024-02, Vol.11 (2), p.477-485

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
Progression prediction is a significant unmet need in people with progressive multiple sclerosis (pwPMS). Studies on glial fibrillary acidic protein (GFAP) have either been limited to single center with relapsing MS or were based solely on Expanded Disability Status Scale (EDSS), which limits its generalizability to state‐of‐the‐art cl...

Alternative Titles

Full title

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_017baefb71394890b530b34dca8c17fc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_017baefb71394890b530b34dca8c17fc

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.51969

How to access this item